Foresite Capital Management V, LLC Theseus Pharmaceuticals, Inc. Transaction History

Foresite Capital Management V, LLC

  • $43.4 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$2.66 - $10.04 $1.39 Million - $5.26 Million
523,450 Added 14.6%
4,108,796 $11.1 Million
Q4 2022

Feb 13, 2023
BUY
$4.69 - $8.36 $1.17 Million - $2.09 Million
250,000 Added 7.5%
3,585,346 $17.9 Million
Q2 2022

Aug 12, 2022
BUY
$5.04 - $14.05 $617,974 - $1.72 Million
122,614 Added 3.82%
3,335,346 $18.4 Million
Q4 2021

Feb 11, 2022
BUY
$8.98 - $20.09 $28.9 Million - $64.5 Million
3,212,732 New
3,212,732 $40.7 Million

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Foresite Capital Management V, LLC Portfolio

Follow Foresite Capital Management V, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management V, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email